AOCNP EXAM REVIEW – QUESTIONS AND ANSWERS |
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES
| GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
1. Pathophysiology and Disease Processes
2. Pharmacology and Treatment Modalities
3. Oncology Nursing Practice and Symptom Management
4. Psychosocial and Supportive Care
5. Ethical and Legal Considerations in Oncology
6. Health Promotion and Survivorship
7. Research and Evidence-Based Practice
8. Advanced Assessment and Diagnostic Reasoning
9. Palliative and End-of-Life Care
10. Interprofessional Collaboration and Communication
Introduction
This comprehensive examination is designed to assess the knowledge, clinical reasoning, and decision-
making skills essential for the Advanced Oncology Certified Nurse Practitioner. The test bank
encompasses foundational theory, applied professional knowledge, regulatory compliance, ethical
standards, and real-world clinical scenarios. Candidates will encounter multiple-choice questions that
evaluate critical thinking, diagnostic acumen, and evidence-based practice. The examination
emphasizes practical application in oncology settings, including symptom management, treatment
planning, psychosocial support, and survivorship care. Each question is accompanied by a detailed
rationale to reinforce learning and ensure a deep understanding of oncological principles. This
resource serves as a vital tool for board examination preparation and clinical practice enhancement.
SECTION ONE: QUESTIONS 1–100
Question 1
A 65-year-old patient with stage III non-small cell lung cancer is receiving concurrent
chemoradiation. The patient reports progressive fatigue, anorexia, and a 5% weight loss over the
,past two weeks. Which intervention should the nurse practitioner prioritize?
A. Prescribe megestrol acetate for appetite stimulation
B. Initiate total parenteral nutrition
C. Assess for tumor progression or treatment-related toxicity
D. Recommend high-calorie liquid supplements
🟢C
🔴 Explanation: The priority intervention is to assess for underlying causes of the symptoms,
including tumor progression or treatment-related toxicity. While nutritional support and appetite
stimulants may be appropriate, the nurse practitioner must first evaluate the etiology of the
symptoms to guide appropriate management.
Question 2
A patient with breast cancer is receiving doxorubicin and cyclophosphamide. Which assessment
finding requires immediate intervention?
A. Heart rate of 92 beats per minute
B. Blood pressure of 138/88 mmHg
C. Dyspnea and jugular venous distension
D. Mild nausea after chemotherapy
🟢C
🔴 Explanation: Dyspnea and jugular venous distension are signs of cardiotoxicity, a known adverse
effect of anthracyclines like doxorubicin. This requires immediate evaluation and intervention to
prevent further cardiac compromise. The other findings are less urgent.
Question 3
When calculating the absolute neutrophil count (ANC) for a patient with a white blood cell count of
2,500 cells/mm³, 60% segmented neutrophils, and 10% bands, what is the ANC?
A. 1,000 cells/mm³
B. 1,500 cells/mm³
C. 1,750 cells/mm³
D. 2,500 cells/mm³
🟢C
🔴 Explanation: The ANC is calculated by multiplying the total WBC count by the percentage of
segmented neutrophils and bands. (2,500 × 0.70 = 1,750 cells/mm³). This is a critical parameter for
assessing infection risk in oncology patients.
,Question 4
A patient with multiple myeloma is experiencing severe bone pain and a pathologic fracture of the
left femur. The nurse practitioner should anticipate which intervention?
A. Initiation of bisphosphonate therapy
B. Radiation therapy to the affected area
C. Surgical stabilization of the fracture
D. High-dose corticosteroids
🟢B
🔴 Explanation: Radiation therapy is indicated for palliation of bone pain and prevention of further
pathologic fractures in multiple myeloma. While bisphosphonates may be used for long-term
management, radiation provides rapid pain relief and helps stabilize lesions.
Question 5
Which tumor marker is most specifically associated with ovarian cancer?
A. CA 19-9
B. CA 125
C. AFP
D. CEA
🟢B
🔴 Explanation: CA 125 is a tumor marker that is elevated in approximately 80% of women with
epithelial ovarian cancer. While not specific for ovarian cancer, it is the most commonly used
marker for monitoring treatment response and detecting recurrence.
Question 6
A patient receiving cisplatin reports tinnitus and hearing loss. The nurse practitioner should
recognize this as:
A. A rare idiosyncratic reaction
B. An expected dose-limiting toxicity
C. A sign of ototoxicity requiring dose modification
D. An indication of drug allergy
🟢C
🔴 Explanation: Cisplatin is known to cause ototoxicity, which manifests as tinnitus and hearing
loss. This toxicity is often cumulative and dose-related, requiring dose modification or
discontinuation to prevent permanent damage. Audiometric monitoring is recommended.
, Question 7
A patient with advanced prostate cancer is being treated with androgen deprivation therapy (ADT).
Which side effect is most commonly associated with this treatment?
A. Weight loss
B. Hot flashes
C. Hypertension
D. Hyperglycemia
🟢B
🔴 Explanation: Hot flashes are one of the most common side effects of androgen deprivation
therapy, occurring in up to 80% of patients due to the sudden decrease in testosterone levels.
Management may include lifestyle modifications or pharmacologic interventions.
Question 8
A patient with acute myeloid leukemia (AML) develops febrile neutropenia. The nurse practitioner
orders blood cultures and initiates empiric antibiotics. Which antibiotic regimen is most
appropriate?
A. Vancomycin monotherapy
B. Ciprofloxacin and metronidazole
C. Ceftazidime or cefepime
D. Ampicillin and gentamicin
🟢C
🔴 Explanation: Empiric antibiotic therapy in febrile neutropenia should provide broad-spectrum
coverage against gram-negative organisms. An antipseudomonal beta-lactam such as ceftazidime
or cefepime is recommended as monotherapy. Additional coverage may be added based on clinical
findings.
Question 9
A patient with Hodgkin lymphoma is scheduled to receive ABVD chemotherapy. Which agent in this
regimen requires pre-treatment pulmonary function testing?
A. Adriamycin (doxorubicin)
B. Bleomycin
C. Vinblastine
D. Dacarbazine
🟢B
🔴 Explanation: Bleomycin is associated with pulmonary toxicity, including pneumonitis and
fibrosis. Pre-treatment pulmonary function testing and baseline chest imaging are recommended to
VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES
| GUARANTEED PASS | LATEST EXAM UPDATE
Core Domains:
1. Pathophysiology and Disease Processes
2. Pharmacology and Treatment Modalities
3. Oncology Nursing Practice and Symptom Management
4. Psychosocial and Supportive Care
5. Ethical and Legal Considerations in Oncology
6. Health Promotion and Survivorship
7. Research and Evidence-Based Practice
8. Advanced Assessment and Diagnostic Reasoning
9. Palliative and End-of-Life Care
10. Interprofessional Collaboration and Communication
Introduction
This comprehensive examination is designed to assess the knowledge, clinical reasoning, and decision-
making skills essential for the Advanced Oncology Certified Nurse Practitioner. The test bank
encompasses foundational theory, applied professional knowledge, regulatory compliance, ethical
standards, and real-world clinical scenarios. Candidates will encounter multiple-choice questions that
evaluate critical thinking, diagnostic acumen, and evidence-based practice. The examination
emphasizes practical application in oncology settings, including symptom management, treatment
planning, psychosocial support, and survivorship care. Each question is accompanied by a detailed
rationale to reinforce learning and ensure a deep understanding of oncological principles. This
resource serves as a vital tool for board examination preparation and clinical practice enhancement.
SECTION ONE: QUESTIONS 1–100
Question 1
A 65-year-old patient with stage III non-small cell lung cancer is receiving concurrent
chemoradiation. The patient reports progressive fatigue, anorexia, and a 5% weight loss over the
,past two weeks. Which intervention should the nurse practitioner prioritize?
A. Prescribe megestrol acetate for appetite stimulation
B. Initiate total parenteral nutrition
C. Assess for tumor progression or treatment-related toxicity
D. Recommend high-calorie liquid supplements
🟢C
🔴 Explanation: The priority intervention is to assess for underlying causes of the symptoms,
including tumor progression or treatment-related toxicity. While nutritional support and appetite
stimulants may be appropriate, the nurse practitioner must first evaluate the etiology of the
symptoms to guide appropriate management.
Question 2
A patient with breast cancer is receiving doxorubicin and cyclophosphamide. Which assessment
finding requires immediate intervention?
A. Heart rate of 92 beats per minute
B. Blood pressure of 138/88 mmHg
C. Dyspnea and jugular venous distension
D. Mild nausea after chemotherapy
🟢C
🔴 Explanation: Dyspnea and jugular venous distension are signs of cardiotoxicity, a known adverse
effect of anthracyclines like doxorubicin. This requires immediate evaluation and intervention to
prevent further cardiac compromise. The other findings are less urgent.
Question 3
When calculating the absolute neutrophil count (ANC) for a patient with a white blood cell count of
2,500 cells/mm³, 60% segmented neutrophils, and 10% bands, what is the ANC?
A. 1,000 cells/mm³
B. 1,500 cells/mm³
C. 1,750 cells/mm³
D. 2,500 cells/mm³
🟢C
🔴 Explanation: The ANC is calculated by multiplying the total WBC count by the percentage of
segmented neutrophils and bands. (2,500 × 0.70 = 1,750 cells/mm³). This is a critical parameter for
assessing infection risk in oncology patients.
,Question 4
A patient with multiple myeloma is experiencing severe bone pain and a pathologic fracture of the
left femur. The nurse practitioner should anticipate which intervention?
A. Initiation of bisphosphonate therapy
B. Radiation therapy to the affected area
C. Surgical stabilization of the fracture
D. High-dose corticosteroids
🟢B
🔴 Explanation: Radiation therapy is indicated for palliation of bone pain and prevention of further
pathologic fractures in multiple myeloma. While bisphosphonates may be used for long-term
management, radiation provides rapid pain relief and helps stabilize lesions.
Question 5
Which tumor marker is most specifically associated with ovarian cancer?
A. CA 19-9
B. CA 125
C. AFP
D. CEA
🟢B
🔴 Explanation: CA 125 is a tumor marker that is elevated in approximately 80% of women with
epithelial ovarian cancer. While not specific for ovarian cancer, it is the most commonly used
marker for monitoring treatment response and detecting recurrence.
Question 6
A patient receiving cisplatin reports tinnitus and hearing loss. The nurse practitioner should
recognize this as:
A. A rare idiosyncratic reaction
B. An expected dose-limiting toxicity
C. A sign of ototoxicity requiring dose modification
D. An indication of drug allergy
🟢C
🔴 Explanation: Cisplatin is known to cause ototoxicity, which manifests as tinnitus and hearing
loss. This toxicity is often cumulative and dose-related, requiring dose modification or
discontinuation to prevent permanent damage. Audiometric monitoring is recommended.
, Question 7
A patient with advanced prostate cancer is being treated with androgen deprivation therapy (ADT).
Which side effect is most commonly associated with this treatment?
A. Weight loss
B. Hot flashes
C. Hypertension
D. Hyperglycemia
🟢B
🔴 Explanation: Hot flashes are one of the most common side effects of androgen deprivation
therapy, occurring in up to 80% of patients due to the sudden decrease in testosterone levels.
Management may include lifestyle modifications or pharmacologic interventions.
Question 8
A patient with acute myeloid leukemia (AML) develops febrile neutropenia. The nurse practitioner
orders blood cultures and initiates empiric antibiotics. Which antibiotic regimen is most
appropriate?
A. Vancomycin monotherapy
B. Ciprofloxacin and metronidazole
C. Ceftazidime or cefepime
D. Ampicillin and gentamicin
🟢C
🔴 Explanation: Empiric antibiotic therapy in febrile neutropenia should provide broad-spectrum
coverage against gram-negative organisms. An antipseudomonal beta-lactam such as ceftazidime
or cefepime is recommended as monotherapy. Additional coverage may be added based on clinical
findings.
Question 9
A patient with Hodgkin lymphoma is scheduled to receive ABVD chemotherapy. Which agent in this
regimen requires pre-treatment pulmonary function testing?
A. Adriamycin (doxorubicin)
B. Bleomycin
C. Vinblastine
D. Dacarbazine
🟢B
🔴 Explanation: Bleomycin is associated with pulmonary toxicity, including pneumonitis and
fibrosis. Pre-treatment pulmonary function testing and baseline chest imaging are recommended to
